ACB $2.450 (-2.78%)

ACNNF $0.120 (-3.23%)

AERO $0.975 (1.56%)

AGEEF $0.244 (-2.32%)

ALEAF $0.475 (-2.46%)

AMMJ $0.149 (2.41%)

APHA $4.890 (-1.21%)

ARNA $46.900 (-3.12%)

ATT:CNX $0.080 (0%)

ATTBF $0.004 (-26.64%)

AUSA:CNX $0.450 (0%)

AUSAF $0.340 (0%)

AVXL $2.360 (-0.42%)

BAMM:CNX $0.700 (0%)

BBM:CNX $0.095 (5.56%)

BBRRF $0.070 (-3.29%)

BE:CNX $0.020 (0%)

BIO:CNX $0.190 (2.7%)

BLEVF $0.017 (-15%)

BLO:CNX $0.410 (-12.77%)

BLOZF $0.322 (-8.11%)

BUDZ $0.361 (7.76%)

BXNG $0.450 (19.95%)

CADMF $0.070 (19.45%)

CALI:CNX $0.080 (-5.88%)

CANN $0.675 (0.67%)

CARA $16.350 (-3.08%)

CBII:CNX $0.095 (5.56%)

CBIIF $0.091 (14.61%)

CBWTF $0.460 (-1.14%)

CGC $20.250 (0.8%)

CGRW $0.141 (2.39%)

CHOO:CNX $0.155 (6.9%)

CHOOF $0.116 (5.64%)

CNAB $0.160 (11.82%)

CNBX $0.103 (-12.12%)

CNGGF $0.265 (-22.09%)

CODI $24.430 (-0.29%)

CPMD $1.110 (0%)

CRBP $4.920 (0.61%)

CRON $6.820 (-0.15%)

CROP:CNX $0.010 (0%)

CRTPF $2.970 (-1.33%)

CRXPF $0.009 (-24.43%)

CSI:CNX $0.090 (20%)

CTST $0.819 (-2.09%)

CURR $2.400 (-6.8%)

CVSI $1.120 (6.67%)

DIGP $0.089 (3.73%)

DXBRF $0.210 (2.44%)

EAPH $0.001 (25%)

EAT:CNX $0.040 (0%)

EEVVF $0.108 (-6.82%)

EMHTF $0.218 (-3.29%)

EPWCF $0.028 (0%)

EVIO $0.058 (-14.71%)

FFRMF $0.032 (-11.94%)

FFT:CNX $0.040 (-11.11%)

FNNZF $0.070 (3.38%)

FSDDF $4.158 (-6.14%)

GGTTF $0.162 (-10.11%)

GLDFF $0.016 (-7.19%)

GLH:CNX $0.020 (33.33%)

GLNNF $0.035 (16%)

GNBT $0.615 (2.5%)

GRIN:CNX $0.120 (14.29%)

GRWG $4.582 (4.61%)

GSTR:CNX $0.095 (5.56%)

GTBIF $8.270 (-0.63%)

GTII:CNX $10.900 (-0.73%)

GWPH $102.880 (0.41%)

HEXO $2.190 (0%)

HHPHF $0.032 (0%)

HLSPY $0.653 (3.83%)

HMLSF $6.857 (-0.75%)

HMPPF $0.498 (0%)

HRVOF $0.135 (3.61%)

HSTRF $0.244 (0%)

HUGE:CNX $5.260 (-10.09%)

IAN:CNX $1.560 (1.3%)

IGC $0.685 (-3.93%)

IGXT $0.530 (3.9%)

IIPR $73.420 (-0.92%)

IMLFF $0.186 (-4.49%)

INQD $0.002 (25%)

IONC:CNX $0.030 (0%)

IONKF $0.028 (-0.71%)

ISOL:CNX $0.185 (2.78%)

ISOLF $0.130 (1.45%)

ITHUF $1.180 (1.72%)

IVITF $0.089 (-3.04%)

JWCAF $0.172 (3.92%)

KALTF $0.039 (11.43%)

KBEV:CNX $0.140 (-6.67%)

KBEVF $0.104 (-13.33%)

KHRNF $0.702 (1.74%)

KSHB $1.600 (-0.62%)

LHS:CNX $0.680 (-2.86%)

LHSIF $0.523 (-0.78%)

LOVE:CNX $0.130 (-3.7%)

LXLLF $0.377 (0%)

LXRP $0.370 (-4.76%)

LXX:CNX $0.490 (-7.55%)

MCIG $0.024 (-16.07%)

MDCL $2.700 (-1.46%)

MEDIF $2.550 (-2.3%)

MGWFF $0.040 (5.26%)

MICWF $0.089 (-1.34%)

MJ:CNX $0.145 (-6.45%)

MJNA $0.025 (0.4%)

MNTR $0.075 (0%)

MRRCF $0.008 (-26.32%)

MWM:CNX $0.125 (4.17%)

MYM:CNX $0.120 (0%)

MYMMF $0.092 (0.28%)

NCNNF $0.258 (3.12%)

NDVAF $0.153 (1.62%)

NGW:CNX $0.115 (4.55%)

NRXCF $0.020 (0%)

NSPDF $0.049 (-6.63%)

NTEC $0.527 (-11.3%)

NVTQF $0.123 (0%)

NWKRF $0.424 (0%)

NXGWF $0.080 (-12.83%)

NXTTF $0.240 (-4%)

OH:CNX $4.220 (3.18%)

ORHOF $3.254 (5.3%)

OWCP $0.007 (4.6%)

PHGI:CNX $0.290 (1.75%)

PHGRF $0.222 (5.67%)

PHVAF $0.091 (1.44%)

PILL:CNX $0.430 (0%)

PKG:CNX $0.105 (0%)

PLPRF $1.225 (2.95%)

PLUS:CNX $1.590 (0.63%)

PMCB $0.045 (40%)

PNPL $0.160 (0%)

POTN $0.027 (10.2%)

PRCNF $0.072 (1.98%)

PTNYF $0.085 (1.98%)

QCA:CNX $0.110 (0%)

RDDTF $0.328 (-2.9%)

RLLVF $0.023 (10.14%)

RMHB $0.024 (13.27%)

RQB:CNX $0.125 (4.17%)

RQHTF $0.390 (-1.86%)

RVVQF $0.086 (-0.23%)

SLNG:CNX $0.390 (0%)

SMG $103.160 (2.2%)

SNN:CNX $0.305 (5.17%)

SNNVF $0.230 (0.58%)

SOL:CNX $0.440 (0%)

SOLCF $0.330 (-2.28%)

SPLIF $0.031 (-3.13%)

SPRWF $0.480 (-2.65%)

SRNA $0.085 (-7.1%)

STEM:CNX $1.110 (0%)

STMH $0.840 (0.3%)

SUN:CNX $0.195 (2.63%)

TBPMF $0.390 (11.4%)

TCAN:CNX $0.680 (6.25%)

TCNAF $0.512 (2.34%)

TER:CNX $2.350 (-5.24%)

TGEN $2.230 (-2.62%)

TGIF:CNX $0.195 (-7.14%)

TGIFF $0.152 (-3.8%)

THC:CNX $0.140 (-3.45%)

THCBF $0.110 (2.04%)

TLRY $18.190 (-1.94%)

TOKI:CNX $0.035 (0%)

TRLFF $0.110 (-5.62%)

TRPX $1.285 (-3.38%)

TRSSF $1.790 (-4.79%)

TRTC $0.180 (10.71%)

TURV $0.078 (-17.81%)

VBIO $0.060 (0%)

VIDA:CNX $0.115 (4.55%)

VIN:CNX $0.020 (-20%)

VPRB $0.039 (13.24%)

VRNDF $0.330 (3.3%)

VRT:CNX $0.220 (0%)

VRTHF $0.140 (26.35%)

VVCIF $0.162 (-1.58%)

WAYL:CNX $0.740 (0%)

WDDMF $0.686 (-1.02%)

WLDFF $0.150 (1.28%)

XXII $0.913 (-0.38%)

ZDPY $0.248 (10.11%)

ZYNE $5.610 (-2.26%)

Technical420 Site Search

Returned 29 result(s).

3 Canadian Licensed Producers Investors Need To Be Watching This Week

Canadian Licensed Producers (LPs) have been heavily impacted by the recent weakness in the cannabis sector and this is a trend that we continue to follow. Although the entire sector has been under pressure, Canadian LPs have been some of the hardest hit and we believe that a number of…

Emerald Health Therapeutics Appoints Chief Executive Officer

VICTORIA, British Columbia, July 30, 2019  -- Emerald Health Therapeutics, Inc. “Emerald” (TSXV: EMH; OTCQX: EMHTF) has appointed Riaz Bandali as Chief Executive Officer. Mr. Bandali has over 25 years of experience in life sciences, with expertise in global operations, strategy development, innovation cultivation, M&A, and investment management spanning contract…

Emerald Health Therapeutics Expands Distribution of its SYNC 25 CBD Oil to Two More Canadian Provinces

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 9,960 40-ml units of its SYNC 25 CBD oil to Alberta and Saskatchewan. The Emerald-branded Indica-dominant CBD oil offers consumers a smoke-free product alternative. “CBD oil has become an increasingly popular product on the market today, and our cannabis-derived…

Emerald Health Therapeutics Joint Venture Launches Cannabis-Free Endocannabinoid-Supporting Health Supplement in Canada

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), through its joint venture Emerald Health Naturals (“EHN”), has introduced a cannabis-free herbal and botanical endocannabinoid-supporting health supplement product line in Canada. EHN’s Endo products, which do not contain cannabis or its derivatives, aim to support the endocannabinoid system to help…

Emerald Health Therapeutics Announces Pure Sunfarms’ Receipt of Standard Processing License for Delta 3 Greenhouse Facility

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received a Standard Processing License (the “Processing License”) from Health Canada for its 1.1 million square foot Delta 3 greenhouse facility. The Processing License permits Pure…

Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Growth in Q1 2019

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the fourth quarter and year ended December 31, 2018. Highlights Emerald’s Q4 sales of $1.1 million was more than triple the prior quarter and year-over year; Q1 2019 sales were $2.6 million. Quebec-based Verdélite subsidiary expected to…

5 Canadian LP Updates Investors Need To Know

The last week has been a relatively busy period for Canadian Licensed Producers (LPs) and this a trend to be watching. Last year, Canada legalized recreational cannabis, and this was a major catalyst for the companies that are levered to this market. Later this year, we expect to see a…

Emerald Health Therapeutics Secures Proprietary Extraction Technology and Extraction Capabilities in Agreement with Indena

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) has entered into a license with Indena S.p.A. of Milan, Italy, bearing certain exclusivity rights in Canada to use Indena’s cannabidiol extraction technology, and contract manufacturing services for CBD extraction. In addition, Emerald has obtained exclusive use of Indena’s proprietary Phytosome® technology for the…

Emerald Health Therapeutics Announces Secondary Offering

Emerald Health Therapeutics, Inc. (TSXV:EMH) today announced that Emerald Health Sciences Inc. has entered into a share purchase agreement with a single Canadian institutional accredited investor in connection with a secondary offering of common shares of the Company. Pursuant to the Share Purchase Agreement, the Investor will purchase 2,800,000 common shares of the Company from…

Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF)  is pleased to announce that, further to its news releases dated April 17, 2018 and November 19, 2018, it has closed its 51:49 joint venture with San Diego-based Emerald Health Bioceuticals, called Emerald Health Naturals.Emerald has invested $5,000,000 for 51% equity ownership of EHN. EHB…

Older Posts »

Search Again